Xbiotech to launch novel candidate therapy for stroke

Company commencing phase i/ii study to test safety and efficacy of its new drug candidate to reduce brain injury after stroke company commencing phase i/ii study to test safety and efficacy of its new drug candidate to reduce brain injury after stroke

XBIT Ratings Summary

XBIT Quant Ranking